| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
19,914 |
16,440 |
$1.58M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,296 |
4,459 |
$591K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
5,119 |
4,717 |
$527K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,206 |
4,672 |
$522K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,969 |
4,675 |
$490K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
9,337 |
8,140 |
$424K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,662 |
3,431 |
$414K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
21,254 |
18,424 |
$165K |
| 99215 |
Prolong outpt/office vis |
1,077 |
830 |
$153K |
| 92557 |
|
4,379 |
3,986 |
$147K |
| 90733 |
|
1,448 |
1,307 |
$129K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,122 |
811 |
$115K |
| 92551 |
|
10,425 |
8,657 |
$86K |
| 92081 |
|
2,955 |
2,604 |
$85K |
| 90670 |
|
3,165 |
2,722 |
$72K |
| 90686 |
|
2,522 |
2,425 |
$56K |
| 90680 |
|
2,577 |
2,210 |
$48K |
| 90698 |
|
2,408 |
2,065 |
$46K |
| 95930 |
|
652 |
634 |
$43K |
| 90716 |
|
1,878 |
1,681 |
$41K |
| 90633 |
|
1,956 |
1,736 |
$40K |
| 90707 |
|
1,870 |
1,667 |
$39K |
| 90677 |
|
654 |
584 |
$38K |
| 90651 |
|
1,777 |
1,592 |
$37K |
| 90744 |
|
1,833 |
1,569 |
$35K |
| 99177 |
|
6,631 |
6,240 |
$30K |
| 94760 |
|
17,510 |
13,858 |
$24K |
| 90697 |
|
889 |
781 |
$24K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
183 |
173 |
$21K |
| 96127 |
|
4,691 |
4,359 |
$20K |
| 90715 |
|
790 |
711 |
$16K |
| 90696 |
|
714 |
641 |
$15K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
656 |
566 |
$15K |
| 0071A |
|
363 |
338 |
$13K |
| 0072A |
|
334 |
319 |
$12K |
| 2015F |
|
1,534 |
1,265 |
$12K |
| 99173 |
|
4,271 |
3,691 |
$8K |
| 96161 |
|
4,321 |
3,322 |
$7K |
| 0002A |
|
184 |
173 |
$7K |
| 0001A |
|
185 |
169 |
$6K |
| 93000 |
|
424 |
392 |
$6K |
| 90700 |
|
293 |
266 |
$6K |
| 90647 |
|
274 |
248 |
$5K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
261 |
205 |
$5K |
| 86580 |
|
985 |
883 |
$5K |
| 90685 |
|
185 |
170 |
$4K |
| 90621 |
|
139 |
134 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
88 |
76 |
$3K |
| 90688 |
|
174 |
94 |
$3K |
| 3008F |
|
4,958 |
4,465 |
$3K |
| 36400 |
|
238 |
158 |
$3K |
| 87400 |
|
469 |
178 |
$2K |
| 99243 |
|
23 |
16 |
$2K |
| 99051 |
|
420 |
290 |
$2K |
| 99070 |
|
420 |
356 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
19 |
17 |
$2K |
| 0240U |
|
27 |
18 |
$1K |
| A4558 |
Conductive gel or paste, for use with electrical device (e.g., tens, nmes), per oz |
397 |
363 |
$1K |
| 0004A |
|
15 |
15 |
$600.00 |
| 90710 |
|
24 |
24 |
$535.44 |
| S0316 |
Disease management program, follow-up/reassessment |
29 |
28 |
$517.50 |
| 90687 |
|
30 |
13 |
$479.92 |
| 0003A |
|
22 |
15 |
$355.00 |
| 97802 |
|
71 |
70 |
$339.40 |
| 90473 |
|
89 |
50 |
$298.62 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
51 |
45 |
$280.43 |
| A6411 |
Eye pad, non-sterile, each |
341 |
306 |
$277.43 |
| S3620 |
Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) |
459 |
319 |
$219.00 |
| 99050 |
|
33 |
14 |
$193.68 |
| 99080 |
|
13 |
13 |
$160.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
31 |
30 |
$139.68 |
| A4556 |
Electrodes, (e.g., apnea monitor), per pair |
149 |
128 |
$107.70 |
| 99442 |
|
21 |
18 |
$75.00 |
| 1005F |
|
967 |
795 |
$70.50 |
| 99072 |
|
574 |
530 |
$70.50 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
19 |
14 |
$52.96 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
39 |
24 |
$46.92 |
| 90461 |
|
28 |
26 |
$27.50 |
| 91307 |
|
366 |
272 |
$24.07 |
| 36416 |
|
405 |
283 |
$22.53 |
| 99000 |
|
1,029 |
733 |
$22.50 |
| 91300 |
|
220 |
169 |
$15.02 |
| INVCD |
|
51 |
47 |
$0.00 |